Sequential TACE-SBRT Combined With Targeted Immunotherapy for Patients With Intermediate to Advanced Liver Cancer
ACTIVE_NOT_RECRUITING
Status
Conditions
- HCC - Hepatocellular Carcinoma
- SBRT
- TACE
- Immunotherapy
- Targeted Therapy
Sponsor
Nanfang Hospital, Southern Medical University